Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where procedure alternatives remain limited. Utilize the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pip... https://financefeeds.com/equilend-appoints-fintech-expert-nick-delikaris-as-chief-product-officer/